Skip to Content


In the US, Cetuximab (cetuximab systemic) is a member of the drug class EGFR inhibitors and is used to treat Colorectal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer and Squamous Cell Carcinoma.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Cytostatic agent


Monoclonal antibody against epidermal growth factor receptor

Chemical Name

Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer (WHO)

Foreign Names

  • Cetuximabum (Latin)
  • Cetuximab (German)
  • CĂ©tuximab (French)
  • Cetuximab (Spanish)

Generic Names

Brand Names

  • Erbitux
    Boehringer Ingelheim, China; Bristol-Myers Squibb, Canada; Haemato Pharm, Austria; Healthcare Logistics, New Zealand; ImClone, United States; Merck, Austria; Merck, Belgium; Merck, Switzerland; Merck, Czech Republic; Merck, Ecuador; Merck, Egypt; Merck, Finland; Merck, Georgia; Merck, Greece; Merck, Hong Kong; Merck, Croatia (Hrvatska); Merck, Hungary; Merck, Indonesia; Merck, Israel; Merck, Iceland; Merck, South Korea; Merck, Lithuania; Merck, Mexico; Merck, Malaysia; Merck, Philippines; Merck, Poland; Merck, Serbia; Merck, Sweden; Merck, Slovakia; Merck, Thailand; Merck, Tunisia; Merck, Venezuela; Merck KGAA, Cyprus; Merck Pharma, Italy; Merck S.L., Spain; Merck Serono, Argentina; Merck Serono, Australia; Merck Serono, China; Merck Serono, Germany; Merck Serono, Denmark; Merck Serono, France; Merck Serono, United Kingdom; Merck Serono, Ireland; Merck Serono, Japan; Merck Serono, Norway; Merck Serono, Oman; Merck Serono, Taiwan; Merck Serono, South Africa; Merck Sharp & Dohme, Bosnia & Herzegowina


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.